EXMceuticals obtains its research and development license for its TecLab facilities in Portugal

October 23, 2019

VANCOUVER, BRITISH COLUMBIA, October 23, 2019 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis is pleased to announce that it has obtained the licence for cannabis research and development from ...

EXMCeuticals Inc. provides Corporate Update

September 10, 2019

VANCOUVER, BRITISH COLUMBIA, September 10, 2019 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of cannabis extractions and refined ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries is very pleased to provide ...

EXMCeuticals Inc. appoints cannabis industry leader Tripp Keber as Strategic Advisor to the Board

August 20, 2019

Vancouver, British Columbia, August 20th, 2019 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is proud to announce it has ...

Significant progress in EXMceuticals Portuguese Operations with R&D facility, new project and pilot-scale refinery

July 31, 2019

VANCOUVER, BRITISH COLUMBIA, July 31th, 2019 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis extracted ingredients for the pharmaceutical, therapeutic, nutraceutical, and cosmetic industries, is pleased to provide an update ...

EXMceuticals Inc. issues shares for DEBT

July 24, 2019

VANCOUVER, BRITISH COLUMBIA, July 24, 2019 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), announces the issuance of 75,554 common shares of the Company at a deemed price of $1.35 per share and the issuance of 200,000 ...

EXMceuticals announces new strategic initiative

July 09, 2019

VANCOUVER, BRITISH COLUMBIA, July 9, 2019 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries is very pleased to announce it ...

EXMceuticals Inc Announces Resignation of Director and CFO

July 08, 2019

July 8th, 2019, Vancouver, British Columbia – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) announces that effective as of June 30, 2019 Mr. Christopher Gulka has resigned as the Company’s Chief Financial Officer and member of the ...

EXM Team deployed on the field to build strong partnerships

July 02, 2019

In the last days, EXM attended major conferences related to our activities.First, Cannabis Europa London 2019 is a major conference that took place on June 24-25th. It brings together more than 500 speakers from all around the world to discuss ...

Update on Proposed Acquisition in the Republic of Malawi

June 11, 2019

11 June 2019, Vancouver, British Columbia – EXMceuticals Inc. (CSE:EXM) (FSE:EXM), a cultivator and producer of medical grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to provide an update on the proposed acquisition of ...

EXM obtains its formal licence in Uganda

June 10, 2019

10 June 2019, VANCOUVER, BRITISH COLUMBIA – EXMceuticals Inc. (CSE:EXM) (FSE:EXM), a cultivator and producer of high-grade cannabis extracted ingredients, for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to announce that it has received its formal full authorisations ...